Rheinfelden, Germany

Andreas Mehlin


Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2005-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovations by Andreas Mehlin in Antimicrobial Treatments**

Introduction

Andreas Mehlin, an innovative inventor based in Rheinfelden, Germany, has made significant contributions to the field of antimicrobial treatments. With a portfolio of three patents, his recent work focuses on the development of new methods for treating surfaces to inhibit microbial growth.

Latest Patents

Mehlin's latest inventions include a method for antimicrobial treatment involving substituted 4-aminopyrimidines. This method allows for effective surface treatment by contacting a surface with these compounds. Furthermore, he has patented the use of 2,4-bis(alkylamino)pyrimidines and quinazolines as effective antimicrobials, detailing various chemical structures and functional groups that enhance their efficacy against microbial threats.

Career Highlights

Currently employed at Ciba Specialty Chemicals Corporation, Andreas Mehlin has leveraged his expertise to innovate within the chemical industry. His patents reflect a commitment to addressing health and sanitation challenges through advanced materials science. His work underlines the importance of antimicrobial solutions in various applications, including healthcare and industry.

Collaborations

Throughout his career, Mehlin has collaborated with esteemed colleagues such as Werner Hölzl and Sophie Marquais-Bienewald. These partnerships contribute to a dynamic exchange of ideas and enhance the potential for groundbreaking innovations in their field.

Conclusion

Andreas Mehlin's contributions in the realm of antimicrobial treatments demonstrate his commitment to innovation and the practical applications of his work. As he continues to develop new chemical solutions, his impact on public health and safety through effective surface treatments is undeniable. His patents represent a significant advancement in the ongoing fight against microbial contamination.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…